Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,269 | -28,062 | -136,673 | -97,275 | -64,555 |
| Depreciation Amortization | 4,230 | 2,111 | 9,154 | 9,586 | 6,236 |
| Accounts payable and accrued liabilities | -1,189 | 689 | -2,361 | 526 | -3,468 |
| Other Working Capital | -8,333 | -9,046 | 9,380 | 12,291 | 111 |
| Other Operating Activity | 6,981 | 4,060 | 32,152 | 12,754 | 13,207 |
| Operating Cash Flow | $-57,580 | $-30,248 | $-88,348 | $-62,118 | $-48,469 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,911 | 12,080 | 74,868 | 55,285 | 47,803 |
| PPE Investments | -804 | -539 | -13,736 | -12,756 | -9,491 |
| Net Acquisitions | -9,608 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-22,323 | $11,541 | $61,132 | $42,529 | $38,312 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -10,241 | -10,241 | -10,241 |
| Common Stock Issued | 470 | 366 | 516 | 872 | 572 |
| Other Financing Activity | 74,422 | 17,829 | 0 | 0 | 0 |
| Financing Cash Flow | $74,892 | $18,195 | $-9,725 | $-9,369 | $-9,669 |
| Beginning Cash Position | 49,303 | 49,303 | 86,244 | 86,244 | 86,244 |
| End Cash Position | 44,292 | 48,791 | 49,303 | 57,286 | 66,418 |
| Net Cash Flow | $-5,011 | $-512 | $-36,941 | $-28,958 | $-19,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,580 | -30,248 | -88,348 | -62,118 | -48,469 |
| Capital Expenditure | -804 | -539 | -13,736 | -12,756 | -9,491 |
| Free Cash Flow | -58,384 | -30,787 | -102,084 | -74,874 | -57,960 |